Blog Category:

From Trial Data to Treatment Decisions: Pharmacy-Supported Stepwise Patient Selection for ATT Success

Alzheimer’s disease (AD) remains a leading cause of cognitive decline and functional impairment in older adults, with early diagnosis and intervention offering the greatest opportunity to preserve quality of life. The emergence of novel disease-modifying, amyloid-targeting therapies (ATTs) has created …

What’s Your Protocol? Streamlining Oncology/Pathology Collaboration Throughout the BC Journey

As HER2-low and ultralow classifications reshape metastatic breast cancer (mBC) treatment pathways, many practices still face real-world barriers to accurate testing and timely reporting. Intra-laboratory variability, limited uptake of emerging assays, and fragmented communication across care teams can all lead …

Decoding the ATT Landscape: Mechanisms, Evidence, and the Evolving Role of Pharmacy

Alzheimer’s disease (AD) affects more than 55 million individuals worldwide, leading to progressive decline in memory, cognition, and ability to perform activities of daily living (ADLs). Recent advancements in amyloid-targeting therapies (ATTs) have created new opportunities to alter disease progression …

Case Closed? Diagnosing Idiopathic Hypersomnia Beyond the Usual Suspects

Idiopathic hypersomnia (IH) is a life-disrupting condition characterized by excessive daytime sleepiness (EDS) that makes waking up a daily struggle, limits productivity, and erodes overall quality of life. For many patients with IH, the journey to diagnosis is long and …

Spotlight on LN: Early Detection Meets Personalized Care

Health care professionals involved in lupus nephritis (LN) care face challenges in recognizing early signs of renal involvement in systemic lupus erythematosus, navigating an increasingly expanding treatment landscape, and addressing persistent disparities affecting Black and Latine patients. Missed or delayed …

Bridging the Gaps – Advancing Equity and Multidisciplinary LN Management

Health care professionals (HCPs) managing lupus nephritis (LN) face persistent gaps in equitable care, with disproportionate burden and worse outcomes among Black and Latine patients driven by structural barriers, delayed recognition, and inconsistent access to specialty services. Despite updated guidelines …

Partnering for Success – Patient Engagement and PrEP Adherence Strategies

Across diverse global settings, patient engagement and sustained adherence remain major challenges in HIV prevention, particularly with pre-exposure prophylaxis (PrEP). Barriers such as insufficient provider training in communication strategies, in addition to broader issues such as stigma, limited health literacy, …

Staying Current – Navigating the Latest Advances in PrEP Options

As HIV prevention strategies continue to evolve, healthcare professionals across the globe face persistent knowledge gaps in evaluating and integrating the latest pre-exposure prophylaxis (PrEP) options, including long-acting injectable (LAI) agents. Many clinicians worldwide remain unfamiliar with the mechanisms of …

Elevating the Role of Behavioral Health in Men’s Health Across the Lifespan

Men face unique behavioral health challenges that often go unrecognized due to stigma, cultural norms, and underreporting, leading to disparities in diagnosis and care. Across their lifespan, men’s mental health concerns frequently appear through externalizing behaviors, physical symptoms, or social …